Article: Navigating the Regulatory Landscape for Topical Generics: Outsourcing-Pharma
The development and manufacture of topical generic products poses various challenges for pharma companies and their CDMOs, particularly when it comes to adhering to global regulations.
In this article with Outsourcing Pharma, Lynn Allen, Vice President of Business Development at MedPharm, discusses the evolution of the topical generics market and the key regulatory requirements pharma companies must comply with.
Read the full article here.
MedPharm is a global contract provider of topical and transdermal formulation development services specializing in reducing risk through unique, cost-effective, and industry-leading performance testing models. MedPharm offers innovative dermal/transdermal, respiratory, mucosal membrane, ophthalmic, and ungual product development solutions with locations in the United Kingdom and the United States. For more information, visit MedPharm.com or follow us on LinkedIn.